Global Preimplantation Genetic Diagnostics (PGD) Market Research Report 2024(Status and Outlook)
Report Overview
Preimplantation genetic diagnosis(PGD) is a procedure used prior to implantation to help identifygeneticdefects within embryos. This serves to prevent certaingeneticdiseases or disorders from being passed on to the child.
This report provides a deep insight into the global Preimplantation Genetic Diagnostics (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Preimplantation Genetic Diagnostics (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Preimplantation Genetic Diagnostics (PGD) market in any manner.
Global Preimplantation Genetic Diagnostics (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Market Segmentation (by Type)
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market Segmentation (by Application)
Fertility Clinics
Academic Medical Centers
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Preimplantation Genetic Diagnostics (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Preimplantation genetic diagnosis(PGD) is a procedure used prior to implantation to help identifygeneticdefects within embryos. This serves to prevent certaingeneticdiseases or disorders from being passed on to the child.
This report provides a deep insight into the global Preimplantation Genetic Diagnostics (PGD) market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Preimplantation Genetic Diagnostics (PGD) Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Preimplantation Genetic Diagnostics (PGD) market in any manner.
Global Preimplantation Genetic Diagnostics (PGD) Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Illumina, Inc.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Perkinelmer, Inc.
Cooper Surgical
ABBott Laboratories
Natera, Inc.
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
Beijing Genomics Institute (BGI)
Genea Limited
Hamilton Thorne
FUJIFILM Irvine Scientific
Nidacon International
Vitrolife AB
Merck
INVO Bioscience
IVFtech
Gonagen Medikal
Cook Medical
CellCura
Market Segmentation (by Type)
Preimplantation Genetic Screening
Preimplantation Genetic Diagnosis
Market Segmentation (by Application)
Fertility Clinics
Academic Medical Centers
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Preimplantation Genetic Diagnostics (PGD) Market
- Overview of the regional outlook of the Preimplantation Genetic Diagnostics (PGD) Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Preimplantation Genetic Diagnostics (PGD) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Preimplantation Genetic Diagnostics (PGD)
1.2 Key Market Segments
1.2.1 Preimplantation Genetic Diagnostics (PGD) Segment by Type
1.2.2 Preimplantation Genetic Diagnostics (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Manufacturers (2019-2024)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Preimplantation Genetic Diagnostics (PGD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Preimplantation Genetic Diagnostics (PGD) Sales Sites, Area Served, Product Type
3.6 Preimplantation Genetic Diagnostics (PGD) Market Competitive Situation and Trends
3.6.1 Preimplantation Genetic Diagnostics (PGD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Preimplantation Genetic Diagnostics (PGD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Preimplantation Genetic Diagnostics (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Type (2019-2024)
6.3 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2019-2024)
6.4 Global Preimplantation Genetic Diagnostics (PGD) Price by Type (2019-2024)
7 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Preimplantation Genetic Diagnostics (PGD) Market Sales by Application (2019-2024)
7.3 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) by Application (2019-2024)
7.4 Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
8 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY REGION
8.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.1.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.1.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region
8.2 North America
8.2.1 North America Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina, Inc.
9.1.1 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.1.2 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.1.4 Illumina, Inc. Business Overview
9.1.5 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.1.6 Illumina, Inc. Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.2.2 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 Agilent Technologies, Inc.
9.3.1 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.3.2 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.3.5 Agilent Technologies, Inc. Business Overview
9.3.6 Agilent Technologies, Inc. Recent Developments
9.4 Perkinelmer, Inc.
9.4.1 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.4.2 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.4.4 Perkinelmer, Inc. Business Overview
9.4.5 Perkinelmer, Inc. Recent Developments
9.5 Cooper Surgical
9.5.1 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Basic Information
9.5.2 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Overview
9.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.5.4 Cooper Surgical Business Overview
9.5.5 Cooper Surgical Recent Developments
9.6 ABBott Laboratories
9.6.1 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Basic Information
9.6.2 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Overview
9.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.6.4 ABBott Laboratories Business Overview
9.6.5 ABBott Laboratories Recent Developments
9.7 Natera, Inc.
9.7.1 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.7.2 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.7.4 Natera, Inc. Business Overview
9.7.5 Natera, Inc. Recent Developments
9.8 Rubicon Genomics
9.8.1 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
9.8.2 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
9.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.8.4 Rubicon Genomics Business Overview
9.8.5 Rubicon Genomics Recent Developments
9.9 Oxford Gene Technology
9.9.1 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Basic Information
9.9.2 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Overview
9.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.9.4 Oxford Gene Technology Business Overview
9.9.5 Oxford Gene Technology Recent Developments
9.10 Yikon Genomics
9.10.1 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
9.10.2 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
9.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.10.4 Yikon Genomics Business Overview
9.10.5 Yikon Genomics Recent Developments
9.11 Scigene
9.11.1 Scigene Preimplantation Genetic Diagnostics (PGD) Basic Information
9.11.2 Scigene Preimplantation Genetic Diagnostics (PGD) Product Overview
9.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.11.4 Scigene Business Overview
9.11.5 Scigene Recent Developments
9.12 Beijing Genomics Institute (BGI)
9.12.1 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Basic Information
9.12.2 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Overview
9.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.12.4 Beijing Genomics Institute (BGI) Business Overview
9.12.5 Beijing Genomics Institute (BGI) Recent Developments
9.13 Genea Limited
9.13.1 Genea Limited Preimplantation Genetic Diagnostics (PGD) Basic Information
9.13.2 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Overview
9.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.13.4 Genea Limited Business Overview
9.13.5 Genea Limited Recent Developments
9.14 Hamilton Thorne
9.14.1 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Basic Information
9.14.2 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Overview
9.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.14.4 Hamilton Thorne Business Overview
9.14.5 Hamilton Thorne Recent Developments
9.15 FUJIFILM Irvine Scientific
9.15.1 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Basic Information
9.15.2 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Overview
9.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.15.4 FUJIFILM Irvine Scientific Business Overview
9.15.5 FUJIFILM Irvine Scientific Recent Developments
9.16 Nidacon International
9.16.1 Nidacon International Preimplantation Genetic Diagnostics (PGD) Basic Information
9.16.2 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Overview
9.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.16.4 Nidacon International Business Overview
9.16.5 Nidacon International Recent Developments
9.17 Vitrolife AB
9.17.1 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Basic Information
9.17.2 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Overview
9.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.17.4 Vitrolife AB Business Overview
9.17.5 Vitrolife AB Recent Developments
9.18 Merck
9.18.1 Merck Preimplantation Genetic Diagnostics (PGD) Basic Information
9.18.2 Merck Preimplantation Genetic Diagnostics (PGD) Product Overview
9.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.18.4 Merck Business Overview
9.18.5 Merck Recent Developments
9.19 INVO Bioscience
9.19.1 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Basic Information
9.19.2 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Overview
9.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.19.4 INVO Bioscience Business Overview
9.19.5 INVO Bioscience Recent Developments
9.20 IVFtech
9.20.1 IVFtech Preimplantation Genetic Diagnostics (PGD) Basic Information
9.20.2 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Overview
9.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.20.4 IVFtech Business Overview
9.20.5 IVFtech Recent Developments
9.21 Gonagen Medikal
9.21.1 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Basic Information
9.21.2 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Overview
9.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.21.4 Gonagen Medikal Business Overview
9.21.5 Gonagen Medikal Recent Developments
9.22 Cook Medical
9.22.1 Cook Medical Preimplantation Genetic Diagnostics (PGD) Basic Information
9.22.2 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Overview
9.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.22.4 Cook Medical Business Overview
9.22.5 Cook Medical Recent Developments
9.23 CellCura
9.23.1 CellCura Preimplantation Genetic Diagnostics (PGD) Basic Information
9.23.2 CellCura Preimplantation Genetic Diagnostics (PGD) Product Overview
9.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.23.4 CellCura Business Overview
9.23.5 CellCura Recent Developments
10 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET FORECAST BY REGION
10.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast
10.2 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country
10.2.3 Asia Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region
10.2.4 South America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Preimplantation Genetic Diagnostics (PGD) by Type (2025-2030)
11.1.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Preimplantation Genetic Diagnostics (PGD) by Type (2025-2030)
11.2 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Application (2025-2030)
11.2.1 Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) Forecast by Application
11.2.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Preimplantation Genetic Diagnostics (PGD)
1.2 Key Market Segments
1.2.1 Preimplantation Genetic Diagnostics (PGD) Segment by Type
1.2.2 Preimplantation Genetic Diagnostics (PGD) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET COMPETITIVE LANDSCAPE
3.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Manufacturers (2019-2024)
3.2 Global Preimplantation Genetic Diagnostics (PGD) Revenue Market Share by Manufacturers (2019-2024)
3.3 Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Preimplantation Genetic Diagnostics (PGD) Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Preimplantation Genetic Diagnostics (PGD) Sales Sites, Area Served, Product Type
3.6 Preimplantation Genetic Diagnostics (PGD) Market Competitive Situation and Trends
3.6.1 Preimplantation Genetic Diagnostics (PGD) Market Concentration Rate
3.6.2 Global 5 and 10 Largest Preimplantation Genetic Diagnostics (PGD) Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) INDUSTRY CHAIN ANALYSIS
4.1 Preimplantation Genetic Diagnostics (PGD) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Type (2019-2024)
6.3 Global Preimplantation Genetic Diagnostics (PGD) Market Size Market Share by Type (2019-2024)
6.4 Global Preimplantation Genetic Diagnostics (PGD) Price by Type (2019-2024)
7 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Preimplantation Genetic Diagnostics (PGD) Market Sales by Application (2019-2024)
7.3 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) by Application (2019-2024)
7.4 Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
8 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET SEGMENTATION BY REGION
8.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.1.1 Global Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.1.2 Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region
8.2 North America
8.2.1 North America Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Preimplantation Genetic Diagnostics (PGD) Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Illumina, Inc.
9.1.1 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.1.2 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.1.3 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.1.4 Illumina, Inc. Business Overview
9.1.5 Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.1.6 Illumina, Inc. Recent Developments
9.2 Thermo Fisher Scientific Inc.
9.2.1 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.2.2 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.2.3 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.2.4 Thermo Fisher Scientific Inc. Business Overview
9.2.5 Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.2.6 Thermo Fisher Scientific Inc. Recent Developments
9.3 Agilent Technologies, Inc.
9.3.1 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.3.2 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.3.3 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.3.4 Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
9.3.5 Agilent Technologies, Inc. Business Overview
9.3.6 Agilent Technologies, Inc. Recent Developments
9.4 Perkinelmer, Inc.
9.4.1 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.4.2 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.4.3 Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.4.4 Perkinelmer, Inc. Business Overview
9.4.5 Perkinelmer, Inc. Recent Developments
9.5 Cooper Surgical
9.5.1 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Basic Information
9.5.2 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Overview
9.5.3 Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.5.4 Cooper Surgical Business Overview
9.5.5 Cooper Surgical Recent Developments
9.6 ABBott Laboratories
9.6.1 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Basic Information
9.6.2 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Overview
9.6.3 ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.6.4 ABBott Laboratories Business Overview
9.6.5 ABBott Laboratories Recent Developments
9.7 Natera, Inc.
9.7.1 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
9.7.2 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
9.7.3 Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.7.4 Natera, Inc. Business Overview
9.7.5 Natera, Inc. Recent Developments
9.8 Rubicon Genomics
9.8.1 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
9.8.2 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
9.8.3 Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.8.4 Rubicon Genomics Business Overview
9.8.5 Rubicon Genomics Recent Developments
9.9 Oxford Gene Technology
9.9.1 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Basic Information
9.9.2 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Overview
9.9.3 Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.9.4 Oxford Gene Technology Business Overview
9.9.5 Oxford Gene Technology Recent Developments
9.10 Yikon Genomics
9.10.1 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
9.10.2 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
9.10.3 Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.10.4 Yikon Genomics Business Overview
9.10.5 Yikon Genomics Recent Developments
9.11 Scigene
9.11.1 Scigene Preimplantation Genetic Diagnostics (PGD) Basic Information
9.11.2 Scigene Preimplantation Genetic Diagnostics (PGD) Product Overview
9.11.3 Scigene Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.11.4 Scigene Business Overview
9.11.5 Scigene Recent Developments
9.12 Beijing Genomics Institute (BGI)
9.12.1 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Basic Information
9.12.2 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Overview
9.12.3 Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.12.4 Beijing Genomics Institute (BGI) Business Overview
9.12.5 Beijing Genomics Institute (BGI) Recent Developments
9.13 Genea Limited
9.13.1 Genea Limited Preimplantation Genetic Diagnostics (PGD) Basic Information
9.13.2 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Overview
9.13.3 Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.13.4 Genea Limited Business Overview
9.13.5 Genea Limited Recent Developments
9.14 Hamilton Thorne
9.14.1 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Basic Information
9.14.2 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Overview
9.14.3 Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.14.4 Hamilton Thorne Business Overview
9.14.5 Hamilton Thorne Recent Developments
9.15 FUJIFILM Irvine Scientific
9.15.1 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Basic Information
9.15.2 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Overview
9.15.3 FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.15.4 FUJIFILM Irvine Scientific Business Overview
9.15.5 FUJIFILM Irvine Scientific Recent Developments
9.16 Nidacon International
9.16.1 Nidacon International Preimplantation Genetic Diagnostics (PGD) Basic Information
9.16.2 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Overview
9.16.3 Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.16.4 Nidacon International Business Overview
9.16.5 Nidacon International Recent Developments
9.17 Vitrolife AB
9.17.1 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Basic Information
9.17.2 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Overview
9.17.3 Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.17.4 Vitrolife AB Business Overview
9.17.5 Vitrolife AB Recent Developments
9.18 Merck
9.18.1 Merck Preimplantation Genetic Diagnostics (PGD) Basic Information
9.18.2 Merck Preimplantation Genetic Diagnostics (PGD) Product Overview
9.18.3 Merck Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.18.4 Merck Business Overview
9.18.5 Merck Recent Developments
9.19 INVO Bioscience
9.19.1 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Basic Information
9.19.2 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Overview
9.19.3 INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.19.4 INVO Bioscience Business Overview
9.19.5 INVO Bioscience Recent Developments
9.20 IVFtech
9.20.1 IVFtech Preimplantation Genetic Diagnostics (PGD) Basic Information
9.20.2 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Overview
9.20.3 IVFtech Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.20.4 IVFtech Business Overview
9.20.5 IVFtech Recent Developments
9.21 Gonagen Medikal
9.21.1 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Basic Information
9.21.2 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Overview
9.21.3 Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.21.4 Gonagen Medikal Business Overview
9.21.5 Gonagen Medikal Recent Developments
9.22 Cook Medical
9.22.1 Cook Medical Preimplantation Genetic Diagnostics (PGD) Basic Information
9.22.2 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Overview
9.22.3 Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.22.4 Cook Medical Business Overview
9.22.5 Cook Medical Recent Developments
9.23 CellCura
9.23.1 CellCura Preimplantation Genetic Diagnostics (PGD) Basic Information
9.23.2 CellCura Preimplantation Genetic Diagnostics (PGD) Product Overview
9.23.3 CellCura Preimplantation Genetic Diagnostics (PGD) Product Market Performance
9.23.4 CellCura Business Overview
9.23.5 CellCura Recent Developments
10 PREIMPLANTATION GENETIC DIAGNOSTICS (PGD) MARKET FORECAST BY REGION
10.1 Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast
10.2 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country
10.2.3 Asia Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region
10.2.4 South America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Preimplantation Genetic Diagnostics (PGD) by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Preimplantation Genetic Diagnostics (PGD) by Type (2025-2030)
11.1.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Preimplantation Genetic Diagnostics (PGD) by Type (2025-2030)
11.2 Global Preimplantation Genetic Diagnostics (PGD) Market Forecast by Application (2025-2030)
11.2.1 Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) Forecast by Application
11.2.2 Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Region (M USD)
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Preimplantation Genetic Diagnostics (PGD) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022)
Table 10. Global Market Preimplantation Genetic Diagnostics (PGD) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Preimplantation Genetic Diagnostics (PGD) Sales Sites and Area Served
Table 12. Manufacturers Preimplantation Genetic Diagnostics (PGD) Product Type
Table 13. Global Preimplantation Genetic Diagnostics (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Preimplantation Genetic Diagnostics (PGD)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Preimplantation Genetic Diagnostics (PGD) Market Challenges
Table 22. Global Preimplantation Genetic Diagnostics (PGD) Sales by Type (K Units)
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (M USD)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Type (2019-2024)
Table 25. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Type (2019-2024)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) by Type (2019-2024)
Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Type (2019-2024)
Table 28. Global Preimplantation Genetic Diagnostics (PGD) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Application
Table 30. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application
Table 31. Global Preimplantation Genetic Diagnostics (PGD) Sales by Application (2019-2024) & (K Units)
Table 32. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application (2019-2024)
Table 33. Global Preimplantation Genetic Diagnostics (PGD) Sales by Application (2019-2024) & (M USD)
Table 34. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2019-2024)
Table 35. Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
Table 36. Global Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 37. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region (2019-2024)
Table 38. North America Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 41. South America Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 43. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 44. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 45. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina, Inc. Business Overview
Table 47. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 48. Illumina, Inc. Recent Developments
Table 49. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 50. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 51. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 54. Thermo Fisher Scientific Inc. Recent Developments
Table 55. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 56. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 57. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 59. Agilent Technologies, Inc. Business Overview
Table 60. Agilent Technologies, Inc. Recent Developments
Table 61. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 62. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 63. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Perkinelmer, Inc. Business Overview
Table 65. Perkinelmer, Inc. Recent Developments
Table 66. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 67. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 68. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cooper Surgical Business Overview
Table 70. Cooper Surgical Recent Developments
Table 71. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 72. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 73. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. ABBott Laboratories Business Overview
Table 75. ABBott Laboratories Recent Developments
Table 76. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 77. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 78. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Natera, Inc. Business Overview
Table 80. Natera, Inc. Recent Developments
Table 81. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 82. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 83. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Rubicon Genomics Business Overview
Table 85. Rubicon Genomics Recent Developments
Table 86. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 87. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 88. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Oxford Gene Technology Business Overview
Table 90. Oxford Gene Technology Recent Developments
Table 91. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 92. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 93. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Yikon Genomics Business Overview
Table 95. Yikon Genomics Recent Developments
Table 96. Scigene Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 97. Scigene Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 98. Scigene Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Scigene Business Overview
Table 100. Scigene Recent Developments
Table 101. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 102. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing Genomics Institute (BGI) Business Overview
Table 105. Beijing Genomics Institute (BGI) Recent Developments
Table 106. Genea Limited Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 107. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 108. Genea Limited Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Genea Limited Business Overview
Table 110. Genea Limited Recent Developments
Table 111. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 112. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 113. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Hamilton Thorne Business Overview
Table 115. Hamilton Thorne Recent Developments
Table 116. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 117. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 118. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. FUJIFILM Irvine Scientific Business Overview
Table 120. FUJIFILM Irvine Scientific Recent Developments
Table 121. Nidacon International Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 122. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 123. Nidacon International Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Nidacon International Business Overview
Table 125. Nidacon International Recent Developments
Table 126. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 127. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 128. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vitrolife AB Business Overview
Table 130. Vitrolife AB Recent Developments
Table 131. Merck Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 132. Merck Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 133. Merck Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Merck Business Overview
Table 135. Merck Recent Developments
Table 136. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 137. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 138. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. INVO Bioscience Business Overview
Table 140. INVO Bioscience Recent Developments
Table 141. IVFtech Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 142. IVFtech Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 143. IVFtech Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. IVFtech Business Overview
Table 145. IVFtech Recent Developments
Table 146. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 147. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 148. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Gonagen Medikal Business Overview
Table 150. Gonagen Medikal Recent Developments
Table 151. Cook Medical Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 152. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 153. Cook Medical Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Cook Medical Business Overview
Table 155. Cook Medical Recent Developments
Table 156. CellCura Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 157. CellCura Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 158. CellCura Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. CellCura Business Overview
Table 160. CellCura Recent Developments
Table 161. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Preimplantation Genetic Diagnostics (PGD) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Preimplantation Genetic Diagnostics (PGD) Market Size Comparison by Region (M USD)
Table 5. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Manufacturers (2019-2024)
Table 6. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Preimplantation Genetic Diagnostics (PGD) Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Preimplantation Genetic Diagnostics (PGD) Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Preimplantation Genetic Diagnostics (PGD) as of 2022)
Table 10. Global Market Preimplantation Genetic Diagnostics (PGD) Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Preimplantation Genetic Diagnostics (PGD) Sales Sites and Area Served
Table 12. Manufacturers Preimplantation Genetic Diagnostics (PGD) Product Type
Table 13. Global Preimplantation Genetic Diagnostics (PGD) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Preimplantation Genetic Diagnostics (PGD)
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Preimplantation Genetic Diagnostics (PGD) Market Challenges
Table 22. Global Preimplantation Genetic Diagnostics (PGD) Sales by Type (K Units)
Table 23. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Type (M USD)
Table 24. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Type (2019-2024)
Table 25. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Type (2019-2024)
Table 26. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) by Type (2019-2024)
Table 27. Global Preimplantation Genetic Diagnostics (PGD) Market Size Share by Type (2019-2024)
Table 28. Global Preimplantation Genetic Diagnostics (PGD) Price (USD/Unit) by Type (2019-2024)
Table 29. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) by Application
Table 30. Global Preimplantation Genetic Diagnostics (PGD) Market Size by Application
Table 31. Global Preimplantation Genetic Diagnostics (PGD) Sales by Application (2019-2024) & (K Units)
Table 32. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application (2019-2024)
Table 33. Global Preimplantation Genetic Diagnostics (PGD) Sales by Application (2019-2024) & (M USD)
Table 34. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2019-2024)
Table 35. Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
Table 36. Global Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 37. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region (2019-2024)
Table 38. North America Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 39. Europe Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 40. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 41. South America Preimplantation Genetic Diagnostics (PGD) Sales by Country (2019-2024) & (K Units)
Table 42. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales by Region (2019-2024) & (K Units)
Table 43. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 44. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 45. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 46. Illumina, Inc. Business Overview
Table 47. Illumina, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 48. Illumina, Inc. Recent Developments
Table 49. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 50. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 51. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 52. Thermo Fisher Scientific Inc. Business Overview
Table 53. Thermo Fisher Scientific Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 54. Thermo Fisher Scientific Inc. Recent Developments
Table 55. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 56. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 57. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Agilent Technologies, Inc. Preimplantation Genetic Diagnostics (PGD) SWOT Analysis
Table 59. Agilent Technologies, Inc. Business Overview
Table 60. Agilent Technologies, Inc. Recent Developments
Table 61. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 62. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 63. Perkinelmer, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 64. Perkinelmer, Inc. Business Overview
Table 65. Perkinelmer, Inc. Recent Developments
Table 66. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 67. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 68. Cooper Surgical Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 69. Cooper Surgical Business Overview
Table 70. Cooper Surgical Recent Developments
Table 71. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 72. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 73. ABBott Laboratories Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 74. ABBott Laboratories Business Overview
Table 75. ABBott Laboratories Recent Developments
Table 76. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 77. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 78. Natera, Inc. Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 79. Natera, Inc. Business Overview
Table 80. Natera, Inc. Recent Developments
Table 81. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 82. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 83. Rubicon Genomics Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 84. Rubicon Genomics Business Overview
Table 85. Rubicon Genomics Recent Developments
Table 86. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 87. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 88. Oxford Gene Technology Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 89. Oxford Gene Technology Business Overview
Table 90. Oxford Gene Technology Recent Developments
Table 91. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 92. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 93. Yikon Genomics Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 94. Yikon Genomics Business Overview
Table 95. Yikon Genomics Recent Developments
Table 96. Scigene Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 97. Scigene Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 98. Scigene Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 99. Scigene Business Overview
Table 100. Scigene Recent Developments
Table 101. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 102. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 103. Beijing Genomics Institute (BGI) Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 104. Beijing Genomics Institute (BGI) Business Overview
Table 105. Beijing Genomics Institute (BGI) Recent Developments
Table 106. Genea Limited Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 107. Genea Limited Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 108. Genea Limited Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 109. Genea Limited Business Overview
Table 110. Genea Limited Recent Developments
Table 111. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 112. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 113. Hamilton Thorne Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 114. Hamilton Thorne Business Overview
Table 115. Hamilton Thorne Recent Developments
Table 116. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 117. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 118. FUJIFILM Irvine Scientific Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 119. FUJIFILM Irvine Scientific Business Overview
Table 120. FUJIFILM Irvine Scientific Recent Developments
Table 121. Nidacon International Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 122. Nidacon International Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 123. Nidacon International Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 124. Nidacon International Business Overview
Table 125. Nidacon International Recent Developments
Table 126. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 127. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 128. Vitrolife AB Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 129. Vitrolife AB Business Overview
Table 130. Vitrolife AB Recent Developments
Table 131. Merck Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 132. Merck Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 133. Merck Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 134. Merck Business Overview
Table 135. Merck Recent Developments
Table 136. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 137. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 138. INVO Bioscience Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 139. INVO Bioscience Business Overview
Table 140. INVO Bioscience Recent Developments
Table 141. IVFtech Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 142. IVFtech Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 143. IVFtech Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 144. IVFtech Business Overview
Table 145. IVFtech Recent Developments
Table 146. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 147. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 148. Gonagen Medikal Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 149. Gonagen Medikal Business Overview
Table 150. Gonagen Medikal Recent Developments
Table 151. Cook Medical Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 152. Cook Medical Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 153. Cook Medical Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 154. Cook Medical Business Overview
Table 155. Cook Medical Recent Developments
Table 156. CellCura Preimplantation Genetic Diagnostics (PGD) Basic Information
Table 157. CellCura Preimplantation Genetic Diagnostics (PGD) Product Overview
Table 158. CellCura Preimplantation Genetic Diagnostics (PGD) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2024)
Table 159. CellCura Business Overview
Table 160. CellCura Recent Developments
Table 161. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 162. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 163. North America Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 164. North America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 165. Europe Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 166. Europe Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 167. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Region (2025-2030) & (K Units)
Table 168. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Region (2025-2030) & (M USD)
Table 169. South America Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Country (2025-2030) & (K Units)
Table 170. South America Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 171. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Consumption Forecast by Country (2025-2030) & (Units)
Table 172. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Country (2025-2030) & (M USD)
Table 173. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Type (2025-2030) & (K Units)
Table 174. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Type (2025-2030) & (M USD)
Table 175. Global Preimplantation Genetic Diagnostics (PGD) Price Forecast by Type (2025-2030) & (USD/Unit)
Table 176. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) Forecast by Application (2025-2030)
Table 177. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Preimplantation Genetic Diagnostics (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD), 2019-2030
Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) (2019-2030)
Figure 6. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Preimplantation Genetic Diagnostics (PGD) Market Size by Country (M USD)
Figure 11. Preimplantation Genetic Diagnostics (PGD) Sales Share by Manufacturers in 2023
Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Revenue Share by Manufacturers in 2023
Figure 13. Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Preimplantation Genetic Diagnostics (PGD) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type
Figure 18. Sales Market Share of Preimplantation Genetic Diagnostics (PGD) by Type (2019-2024)
Figure 19. Sales Market Share of Preimplantation Genetic Diagnostics (PGD) by Type in 2023
Figure 20. Market Size Share of Preimplantation Genetic Diagnostics (PGD) by Type (2019-2024)
Figure 21. Market Size Market Share of Preimplantation Genetic Diagnostics (PGD) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application
Figure 24. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application (2019-2024)
Figure 25. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application in 2023
Figure 26. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2019-2024)
Figure 27. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application in 2023
Figure 28. Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region (2019-2024)
Figure 30. North America Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 32. U.S. Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Preimplantation Genetic Diagnostics (PGD) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Preimplantation Genetic Diagnostics (PGD) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 37. Germany Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region in 2023
Figure 44. China Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 50. South America Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 51. Brazil Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Preimplantation Genetic Diagnostics (PGD) Market Share Forecast by Type (2025-2030)
Figure 65. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Application (2025-2030)
Figure 66. Global Preimplantation Genetic Diagnostics (PGD) Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Preimplantation Genetic Diagnostics (PGD)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD), 2019-2030
Figure 5. Global Preimplantation Genetic Diagnostics (PGD) Market Size (M USD) (2019-2030)
Figure 6. Global Preimplantation Genetic Diagnostics (PGD) Sales (K Units) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Preimplantation Genetic Diagnostics (PGD) Market Size by Country (M USD)
Figure 11. Preimplantation Genetic Diagnostics (PGD) Sales Share by Manufacturers in 2023
Figure 12. Global Preimplantation Genetic Diagnostics (PGD) Revenue Share by Manufacturers in 2023
Figure 13. Preimplantation Genetic Diagnostics (PGD) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Preimplantation Genetic Diagnostics (PGD) Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Preimplantation Genetic Diagnostics (PGD) Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Type
Figure 18. Sales Market Share of Preimplantation Genetic Diagnostics (PGD) by Type (2019-2024)
Figure 19. Sales Market Share of Preimplantation Genetic Diagnostics (PGD) by Type in 2023
Figure 20. Market Size Share of Preimplantation Genetic Diagnostics (PGD) by Type (2019-2024)
Figure 21. Market Size Market Share of Preimplantation Genetic Diagnostics (PGD) by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application
Figure 24. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application (2019-2024)
Figure 25. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Application in 2023
Figure 26. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application (2019-2024)
Figure 27. Global Preimplantation Genetic Diagnostics (PGD) Market Share by Application in 2023
Figure 28. Global Preimplantation Genetic Diagnostics (PGD) Sales Growth Rate by Application (2019-2024)
Figure 29. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region (2019-2024)
Figure 30. North America Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 31. North America Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 32. U.S. Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 33. Canada Preimplantation Genetic Diagnostics (PGD) Sales (K Units) and Growth Rate (2019-2024)
Figure 34. Mexico Preimplantation Genetic Diagnostics (PGD) Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 36. Europe Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 37. Germany Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 38. France Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 39. U.K. Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 40. Italy Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 41. Russia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 42. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region in 2023
Figure 44. China Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 45. Japan Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 46. South Korea Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 47. India Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 48. Southeast Asia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 49. South America Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 50. South America Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Country in 2023
Figure 51. Brazil Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 52. Argentina Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 53. Columbia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 54. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Preimplantation Genetic Diagnostics (PGD) Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 57. UAE Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 58. Egypt Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 59. Nigeria Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 60. South Africa Preimplantation Genetic Diagnostics (PGD) Sales and Growth Rate (2019-2024) & (K Units)
Figure 61. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Volume (2019-2030) & (K Units)
Figure 62. Global Preimplantation Genetic Diagnostics (PGD) Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Preimplantation Genetic Diagnostics (PGD) Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Preimplantation Genetic Diagnostics (PGD) Market Share Forecast by Type (2025-2030)
Figure 65. Global Preimplantation Genetic Diagnostics (PGD) Sales Forecast by Application (2025-2030)
Figure 66. Global Preimplantation Genetic Diagnostics (PGD) Market Share Forecast by Application (2025-2030)
